Graham Richard A (CIK 0001820036)

Latest company ownership

TBPH - Theravance Biopharma, Inc.
Role: SVP, RESEARCH & DEVELOPMENT
Shares held
314,915
Last filed at
Feb 22, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 20, 2024 Feb 22, 2024 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 42.5 -19,294 -5.77% ✗ $172.1K
Nov 20, 2023 Nov 22, 2023 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 42.5 -12,630 -3.64% ✗ $131K
Nov 14, 2023 Nov 16, 2023 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 51.3 -2,482 -0.71% ✓ $25.4K
Oct 16, 2023 Oct 18, 2023 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 51.3 -2,482 -0.74% ✓ $22.4K
Sep 14, 2023 Sep 18, 2023 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 51.3 -2,482 -0.73% ✓ $24.5K
Aug 20, 2023 Aug 22, 2023 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 42.5 -10,461 -2.99% ✗ $101.5K
Aug 11, 2023 Aug 15, 2023 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 51.3 -2,322 -0.66% ✓ $23.2K
Jul 14, 2023 Jul 18, 2023 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 51.3 -2,322 -0.66% ✓ $22.8K
Jun 14, 2023 Jun 16, 2023 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 51.3 -2,322 -0.65% ✓ $24.8K
May 20, 2023 May 23, 2023 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 42.5 -10,460 -2.85% ✗ $117.3K
May 15, 2023 May 17, 2023 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 51.3 -2,322 -0.63% ✓ $26.1K
Apr 14, 2023 Apr 18, 2023 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 51.3 -2,323 -0.62% ✓ $27.6K
Mar 14, 2023 Mar 16, 2023 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 51.3 -2,323 -0.62% ✓ $24K
Mar 6, 2023 Mar 8, 2023 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 51.3 -2,323 -0.62% ✓ $23.3K
Feb 20, 2023 Feb 22, 2023 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 42.5 -12,057 -3.85% ✗ $125.9K
Dec 1, 2022 Dec 5, 2022 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 36.3 -2,084 -0.66% ✗ $22.4K
Nov 20, 2022 Nov 22, 2022 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 40.0 -27,350 -7.97% ✗ $296.7K
Nov 16, 2022 Nov 17, 2022 Theravance Biopharma, Inc. SVP, RESEARCH & DEVELOPMENT Sell 36.3 -2,800 -0.81% ✗ $31.4K
Aug 19, 2022 Aug 23, 2022 Theravance Biopharma, Inc. SVP, DEVELOPMENT Sell 42.5 -18,991 -5.21% ✗ $177.4K
Aug 16, 2022 Aug 18, 2022 Theravance Biopharma, Inc. SVP, DEVELOPMENT Sell 26.3 -4,906 -1.33% ✗ $47.6K
Aug 9, 2022 Aug 11, 2022 Theravance Biopharma, Inc. SVP, DEVELOPMENT Sell 22.5 -15,086 -3.92% ✗ $132.6K
May 20, 2022 May 24, 2022 Theravance Biopharma, Inc. SVP, DEVELOPMENT Sell 46.3 -3,947 -1.02% ✗ $34.5K
Feb 18, 2022 Feb 23, 2022 Theravance Biopharma, Inc. SVP, DEVELOPMENT Sell 42.5 -20,377 -4.98% ✗ $195.8K
Nov 19, 2021 Nov 23, 2021 Theravance Biopharma, Inc. SVP, DEVELOPMENT Sell 46.3 -4,263 -100.00% ✗ $35.6K
Aug 20, 2021 Aug 24, 2021 Theravance Biopharma, Inc. SVP, Development Sell 42.5 -6,819 -3.79% ✗ $95.8K
May 20, 2021 May 24, 2021 Theravance Biopharma, Inc. SVP, Development Sell 22.5 -3,410 -1.86% ✗ $60.7K
Feb 20, 2021 Feb 23, 2021 Theravance Biopharma, Inc. SVP, Development Sell 22.5 -6,597 -3.50% ✗ $124K
Dec 14, 2020 Dec 16, 2020 Theravance Biopharma, Inc. SVP, Development Sell 22.5 -7,500 -5.71% ✗ $146.1K
Nov 20, 2020 Nov 24, 2020 Theravance Biopharma, Inc. SVP, Development Sell 22.5 -3,876 -2.87% ✗ $66.7K
Aug 20, 2020 Aug 24, 2020 Theravance Biopharma, Inc. SVP, Development Sell 22.5 -6,598 -5.78% ✗ $120.2K